{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:22:27Z","timestamp":1792891347111,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40122-025-00774-y","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:54:28Z","timestamp":1758272068000},"page":"1745-1763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Opioid Use among People with Migraine: Results of the OVERCOME (US) Study"],"prefix":"10.1007","volume":"14","author":[{"given":"Sait","family":"Ashina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jolanda","family":"Muenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn C.","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"issue":"4","key":"774_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018;58(4):496\u2013505.","journal-title":"Headache"},{"issue":"1","key":"774_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain. 2020;21(1):137.","journal-title":"J Headache Pain"},{"key":"774_CR3","unstructured":"Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954\u201376."},{"key":"774_CR4","doi-asserted-by":"crossref","unstructured":"Migraine. Ann Intern Med. 2023;176(1):ITC1-ITC16.","DOI":"10.7326\/AITC202301170"},{"issue":"10283","key":"774_CR5","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Buse DC, Ashina H, Pozo-Rosich P, Peres MFP, Lee MJ, et\u00a0al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet. 2021;397(10283):1505\u201318.","journal-title":"Lancet"},{"issue":"2","key":"774_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1212\/CON.0000000000001402","volume":"30","author":"R Burch","year":"2024","unstructured":"Burch R. Acute treatment of migraine. Continuum (Minneap Minn). 2024;30(2):344\u201363.","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"774_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.11607\/ofph.3163","volume":"37","author":"N George","year":"2023","unstructured":"George N, Tepper SJ. Novel migraine treatments: a review. J Oral Facial Pain Headache. 2023;37(1):25\u201332.","journal-title":"J Oral Facial Pain Headache"},{"issue":"7","key":"774_CR8","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/head.14153","volume":"61","author":"J Ailani","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021\u201339.","journal-title":"Headache"},{"issue":"1","key":"774_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1526-4610.2011.02050.x","volume":"52","author":"DC Buse","year":"2012","unstructured":"Buse DC, Pearlman SH, Reed ML, Serrano D, Ng-Mak DS, Lipton RB. Opioid use and dependence among persons with migraine: results of the AMPP study. Headache. 2012;52(1):18\u201336.","journal-title":"Headache"},{"key":"774_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/JPR.S24170","volume":"4","author":"JA Davis","year":"2011","unstructured":"Davis JA, Robinson RL, Le TK, Xie J. Incidence and impact of pain conditions and comorbid illnesses. J Pain Res. 2011;4:331\u201345.","journal-title":"J Pain Res"},{"issue":"2","key":"774_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1941874412439583","volume":"2","author":"AA Gelfand","year":"2012","unstructured":"Gelfand AA, Goadsby PJ. A neurologist\u2019s guide to acute migraine therapy in the emergency room. Neurohospitalist. 2012;2(2):51\u20139.","journal-title":"Neurohospitalist"},{"issue":"12","key":"774_CR12","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/JOM.0000000000001450","volume":"60","author":"AM Gilligan","year":"2018","unstructured":"Gilligan AM, Foster SA, Sainski-Nguyen A, Sedgley R, Smith D, Morrow P. Direct and indirect costs among United States commercially insured employees with migraine. J Occup Environ Med. 2018;60(12):1120\u20137.","journal-title":"J Occup Environ Med"},{"issue":"5","key":"774_CR13","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1212\/WNL.0000000000009324","volume":"95","author":"RB Lipton","year":"2020","unstructured":"Lipton RB, Buse DC, Friedman BW, Feder L, Adams AM, Fanning KM, et\u00a0al. Characterizing opioid use in a US population with migraine: results from the CaMEO study. Neurology. 2020;95(5):e457\u201368.","journal-title":"Neurology"},{"issue":"4","key":"774_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11910-015-0539-z","volume":"15","author":"MJ Marmura","year":"2015","unstructured":"Marmura MJ, Goldberg SW. Inpatient management of migraine. Curr Neurol Neurosci Rep. 2015;15(4):13.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9","key":"774_CR15","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/head.12645","volume":"55","author":"MT Minen","year":"2015","unstructured":"Minen MT, Lindberg K, Wells RE, Suzuki J, Grudzen C, Balcer L, et\u00a0al. Survey of opioid and barbiturate prescriptions in patients attending a tertiary care headache center. Headache. 2015;55(9):1183\u201391.","journal-title":"Headache"},{"issue":"6","key":"774_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/head.12835","volume":"56","author":"SL Orr","year":"2016","unstructured":"Orr SL, Friedman BW, Christie S, Minen MT, Bamford C, Kelley NE, et\u00a0al. Management of adults with acute migraine in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies. Headache. 2016;56(6):911\u201340.","journal-title":"Headache"},{"issue":"7","key":"774_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/head.12399","volume":"54","author":"MT Minen","year":"2014","unstructured":"Minen MT, Tanev K, Friedman BW. Evaluation and treatment of migraine in the emergency department: a review. Headache. 2014;54(7):1131\u201345.","journal-title":"Headache"},{"issue":"8","key":"774_CR18","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157\u201368.","journal-title":"Headache"},{"issue":"7","key":"774_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1377\/hlthaff.2021.01515","volume":"41","author":"MR Weaver","year":"2022","unstructured":"Weaver MR, Joffe J, Ciarametaro M, Dubois RW, Dunn A, Singh A, et\u00a0al. Health care spending effectiveness: estimates suggest that spending improved US health from 1996 to 2016. Health Aff (Millwood). 2022;41(7):994\u20131004.","journal-title":"Health Aff (Millwood)"},{"issue":"14","key":"774_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1001\/jama.2018.0158","volume":"319","author":"Collaborators TUBoD","year":"2018","unstructured":"Collaborators TUBoD. The state of US health, 1990\u20132016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444\u201372.","journal-title":"JAMA"},{"issue":"10208","key":"774_CR21","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et\u00a0al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet. 2019;394(10208):1560\u201379.","journal-title":"Lancet"},{"issue":"1","key":"774_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2105\/AJPH.2018.304881","volume":"109","author":"RJ Bonnie","year":"2019","unstructured":"Bonnie RJ, Schumacher MA, Clark JD, Kesselheim AS. Pain management and opioid regulation: continuing public health challenges. Am J Public Health. 2019;109(1):31\u20134.","journal-title":"Am J Public Health"},{"key":"774_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2023.103677","volume":"86","author":"J Shen","year":"2023","unstructured":"Shen J, Hua G, Li C, Liu S, Liu L, Jiao J. Prevalence, incidence, deaths, and disability-adjusted life-years of drug use disorders for 204 countries and territories during the past 30 years. Asian J Psychiatr. 2023;86:103677.","journal-title":"Asian J Psychiatr"},{"key":"774_CR24","unstructured":"McCance-Katz EF. Facing addiction in America: the surgeon general\u2019s spotlight on opioids. US Department of Health and Human Services. 2018."},{"issue":"Suppl 1","key":"774_CR25","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/pme.12904","volume":"16","author":"MD Cheatle","year":"2015","unstructured":"Cheatle MD. Prescription opioid misuse, abuse, morbidity, and mortality: balancing effective pain management and safety. Pain Med. 2015;16(Suppl 1):S3-8.","journal-title":"Pain Med"},{"issue":"1","key":"774_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/head.14018","volume":"61","author":"RB Lipton","year":"2021","unstructured":"Lipton RB, Buse DC, Dodick DW, Schwedt TJ, Singh P, Munjal S, et\u00a0al. Burden of increasing opioid use in the treatment of migraine: results from the Migraine in America Symptoms and Treatment Study. Headache. 2021;61(1):103\u201316.","journal-title":"Headache"},{"issue":"1","key":"774_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-022-00415-0","volume":"9","author":"S Ashina","year":"2023","unstructured":"Ashina S, Terwindt GM, Steiner TJ, Lee MJ, Porreca F, Tassorelli C, et\u00a0al. Medication overuse headache. Nat Rev Dis Primers. 2023;9(1):5.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"774_CR28","first-page":"1272","volume":"28","author":"Q Shao","year":"2022","unstructured":"Shao Q, Rascati KL, Lawson KA, Barner JC, Sonawane KB, Rousseau JF. Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression. J Manag Care Spec Pharm. 2022;28(11):1272\u201381.","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"774_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/0333102415593086","volume":"36","author":"MT Minen","year":"2016","unstructured":"Minen MT, Loder E, Tishler L, Silbersweig D. Migraine diagnosis and treatment: a knowledge and needs assessment among primary care providers. Cephalalgia. 2016;36(4):358\u201370.","journal-title":"Cephalalgia"},{"issue":"10","key":"774_CR30","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/head.12233","volume":"53","author":"E Loder","year":"2013","unstructured":"Loder E, Weizenbaum E, Frishberg B, Silberstein S, Force AHSCWT. Choosing wisely in headache medicine: the American Headache Society\u2019s list of five things physicians and patients should question. Headache. 2013;53(10):1651\u20139.","journal-title":"Headache"},{"key":"774_CR31","unstructured":"2022 Clinical Practice Guideline Recommendations Centers for Disease Control and Prevention: CDC; 2023. Available from: https:\/\/www.cdc.gov\/opioids\/healthcare-professionals\/prescribing\/guideline\/recommendations-principles.html#determining."},{"issue":"2","key":"774_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/head.14259","volume":"62","author":"RB Lipton","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, et\u00a0al. Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study. Headache. 2022;62(2):122\u201340.","journal-title":"Headache"},{"issue":"5","key":"774_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343\u20139.","journal-title":"Neurology"},{"issue":"7","key":"774_CR34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1526-4610.2001.041007638.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41(7):638\u201345.","journal-title":"Headache"},{"issue":"1","key":"774_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"issue":"1\u20132","key":"774_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","volume":"122","author":"B L\u00f6we","year":"2010","unstructured":"L\u00f6we B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, et\u00a0al. A 4-item measure of depression and anxiety: validation and standardization of the patient health questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1\u20132):86\u201395.","journal-title":"J Affect Disord"},{"issue":"9","key":"774_CR37","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/head.13407","volume":"58","author":"RB Lipton","year":"2018","unstructured":"Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, et\u00a0al. Migraine in America symptoms and treatment (MAST) study: baseline study methods, treatment patterns, and gender differences. Headache. 2018;58(9):1408\u201326.","journal-title":"Headache"},{"issue":"suppl 1","key":"774_CR38","first-page":"S40","volume":"50","author":"D Serrano","year":"2010","unstructured":"Serrano D, Buse D, Reed M, Runken M, Lipton R. Development of the Migraine Symptom Severity Score (MSSS): a latent variable model for migraine definition. Headache. 2010;50(suppl 1):S40.","journal-title":"Headache"},{"issue":"9","key":"774_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1526-4610.2001.01156.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41(9):854\u201361.","journal-title":"Headache"},{"issue":"6 Suppl 1","key":"774_CR40","first-page":"S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u20138.","journal-title":"Neurology"},{"issue":"2","key":"774_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1046\/j.1468-2982.1999.019002107.x","volume":"19","author":"WF Stewart","year":"1999","unstructured":"Stewart WF, Lipton R, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia. 1999;19(2):107\u201314.","journal-title":"Cephalalgia"},{"key":"774_CR42","doi-asserted-by":"publisher","first-page":"1032103","DOI":"10.3389\/fneur.2022.1032103","volume":"13","author":"M Vincent","year":"2022","unstructured":"Vincent M, Viktrup L, Nicholson RA, Ossipov MH, Vargas BB. The not so hidden impact of interictal burden in migraine: a narrative review. Front Neurol. 2022;13:1032103.","journal-title":"Front Neurol"},{"issue":"1","key":"774_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-019-0138-x","volume":"3","author":"RM Speck","year":"2019","unstructured":"Speck RM, Shalhoub H, Ayer DW, Ford JH, Wyrwich KW, Bush EN. Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome. J Patient Rep Outcomes. 2019;3(1):39.","journal-title":"J Patient Rep Outcomes"},{"issue":"2","key":"774_CR44","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ana.21211","volume":"63","author":"RB Lipton","year":"2008","unstructured":"Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, et\u00a0al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63(2):148\u201358.","journal-title":"Ann Neurol"},{"issue":"5","key":"774_CR45","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20f13681","volume":"81","author":"C Andrade","year":"2020","unstructured":"Andrade C. Mean difference, standardized mean difference (SMD) and their use in meta-analysis:\nas simple as it gets. J Clin Psychiatry. 2020;81(5):20f13681.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"774_CR46","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1214\/009053607000000127","volume":"35","author":"H Zou","year":"2007","unstructured":"Zou H, Hastie T, Tibshirani R. On the \u201cdegrees of freedom\u201d of the LASSO. Ann Statist. 2007;35(5):2173\u201392.","journal-title":"Ann Statist."},{"issue":"Suppl 1","key":"774_CR47","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1007\/s10072-013-1395-8","volume":"34","author":"G Casucci","year":"2013","unstructured":"Casucci G, Cevoli S. Controversies in migraine treatment: opioids should be avoided. Neurol Sci. 2013;34(Suppl 1):S125\u20138.","journal-title":"Neurol Sci"},{"issue":"1","key":"774_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.12499","volume":"55","author":"MJ Marmura","year":"2015","unstructured":"Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3\u201320.","journal-title":"Headache"},{"issue":"10","key":"774_CR49","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/j.1526-4610.2010.01755.x","volume":"50","author":"F Radat","year":"2010","unstructured":"Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication-overuse headache? Headache. 2010;50(10):1597\u2013611.","journal-title":"Headache"},{"issue":"3","key":"774_CR50","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/WCO.0000000000000925","volume":"34","author":"MW Green","year":"2021","unstructured":"Green MW. Medication overuse headache. Curr Opin Neurol. 2021;34(3):378\u201383.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"774_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10194-018-0865-z","volume":"19","author":"TJ Schwedt","year":"2018","unstructured":"Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC, et\u00a0al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018;19(1):38.","journal-title":"J Headache Pain"},{"issue":"1","key":"774_CR52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s10194-016-0696-8","volume":"17","author":"K Thorlund","year":"2016","unstructured":"Thorlund K, Sun-Edelstein C, Druyts E, Kanters S, Ebrahim S, Bhambri R, et\u00a0al. Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain. 2016;17(1):107.","journal-title":"J Headache Pain"},{"issue":"1","key":"774_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jns.2014.11.004","volume":"348","author":"A Raggi","year":"2015","unstructured":"Raggi A, Schiavolin S, Leonardi M, Giovannetti AM, Bussone G, Curone M, et\u00a0al. Chronic migraine with medication overuse: association between disability and quality of life measures, and impact of disease on patients\u2019 lives. J Neurol Sci. 2015;348(1):60\u20136.","journal-title":"J Neurol Sci"},{"issue":"22","key":"774_CR54","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1212\/01.wnl.0000335946.53860.1d","volume":"71","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008;71(22):1821\u20138.","journal-title":"Neurology"},{"key":"774_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12020589","author":"TJ Schnitzer","year":"2023","unstructured":"Schnitzer TJ, Robinson RL, Viktrup L, Cappelleri JC, Bushmakin AG, Tive L, et\u00a0al. Opioid prescribing for osteoarthritis: cross-sectional survey among primary care physicians, rheumatologists, and orthopaedic surgeons. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12020589.","journal-title":"J Clin Med"},{"issue":"1","key":"774_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10194-018-0899-2","volume":"20","author":"TJ Steiner","year":"2019","unstructured":"Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, et\u00a0al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache. J Headache Pain. 2019;20(1):57.","journal-title":"J Headache Pain"},{"key":"774_CR57","unstructured":"Buse DC, Nicholson RA, Araujo AB, Reed ML, Shapiro RE, Ashina S, et al. Migraine Care across the healthcare landscape in the United States among those with \u22654 migraine headache days per month: results of the OVERCOME study. Presented at: American Headache Society 61st Annual Scientific Meeting; July 11-14, 2019; Philadelphia, PA. Headache. 2019;59:1-208."},{"issue":"4","key":"774_CR58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102414539055","volume":"35","author":"BW Friedman","year":"2015","unstructured":"Friedman BW, West J, Vinson DR, Minen MT, Restivo A, Gallagher EJ. Current management of migraine in US emergency departments: an analysis of the National Hospital Ambulatory Medical Care Survey. Cephalalgia. 2015;35(4):301\u20139.","journal-title":"Cephalalgia"},{"issue":"Suppl 2","key":"774_CR59","first-page":"S87","volume":"18","author":"SM Motov","year":"2011","unstructured":"Motov SM, Marshall JP. Acute pain management curriculum for emergency medicine residency programs. Acad Emerg Med. 2011;18(Suppl 2):S87-91.","journal-title":"Acad Emerg Med"},{"key":"774_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ajem.2020.09.021","volume":"45","author":"A Banerjee","year":"2021","unstructured":"Banerjee A, Dreisbach E, Smyres C, Ence T, Brennan J, Coyne CJ. Barriers to medication adherence in the emergency department: a cross-sectional study. Am J Emerg Med. 2021;45:415\u20139.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"774_CR61","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.annemergmed.2013.02.002","volume":"62","author":"ML McCarthy","year":"2013","unstructured":"McCarthy ML, Ding R, Roderer NK, Steinwachs DM, Ortmann MJ, Pham JC, et\u00a0al. Does providing prescription information or services improve medication adherence among patients discharged from the emergency department? A randomized controlled trial. Ann Emerg Med. 2013;62(3):212-23.e1.","journal-title":"Ann Emerg Med"},{"key":"774_CR62","doi-asserted-by":"publisher","first-page":"215013272096368","DOI":"10.1177\/2150132720963680","volume":"11","author":"DW Dodick","year":"2020","unstructured":"Dodick DW, Shewale AS, Lipton RB, Baum SJ, Marcus SC, Silberstein SD, et\u00a0al. Migraine patients with cardiovascular disease and contraindications: an analysis of real-world claims data. J Prim Care Community Health. 2020;11:2150132720963680.","journal-title":"J Prim Care Community Health"},{"issue":"6","key":"774_CR63","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.annemergmed.2023.05.024","volume":"82","author":"MA Cortel-LeBlanc","year":"2023","unstructured":"Cortel-LeBlanc MA, Orr SL, Dunn M, James D, Cortel-LeBlanc A. Managing and preventing migraine in the emergency department: a review. Ann Emerg Med. 2023;82(6):732\u201351.","journal-title":"Ann Emerg Med"},{"key":"774_CR64","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Pharmacological management of migraine. Guideline SIGN 155. 2023."},{"key":"774_CR65","unstructured":"National Institute for Health and Care Excellence (NICE). Headaches in over 12s: diagnosis and management 2012."},{"issue":"9","key":"774_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11916-016-0581-9","volume":"20","author":"MT Stone","year":"2016","unstructured":"Stone MT, Weed V, Kulich RJ. Opioid treatment of migraine: risk factors and behavioral issues. Curr Pain Headache Rep. 2016;20(9):51.","journal-title":"Curr Pain Headache Rep"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00774-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-025-00774-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-025-00774-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:06:11Z","timestamp":1763640371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-025-00774-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["774"],"URL":"https:\/\/doi.org\/10.1007\/s40122-025-00774-y","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sait Ashina, MD, has served as a consultant and\/or advisory board member or has received honoraria from Allergan\/AbbVie, Amgen, Biohaven Pharmaceuticals, Eli Lilly and Company, Impel NeuroPharma, Novartis, Satsuma, Supernus, Percept, Pfizer, Teva, and Theranica. Elizabeth Johnston, PharmD, is an employee and minor stockholder of Eli Lilly and Company. E. Jolanda Muenzel, MD, Ph.D., is an employee and minor stockholder of Eli Lilly and Company. Gilwan Kim, PharmD, is an employee and minor stockholder of Eli Lilly and Company. Dawn C. Buse, Ph.D., has received research support from the Food and Drug Administration (FDA) and the National Headache Foundation; she serves as consultant, advisory board member or has received honoraria or research support from AbbVie\/Allergan, Amgen, Biohaven, Eli Lilly and Company, Lundbeck, Novartis, and Teva and Theranica. Michael L. Reed, Ph.D., has received research support from the National Headache Foundation; he serves as a consultant and\/or advisory board member or has received honoraria or research support from AbbVie\/Allergan, Amgen, Dr. Reddy\u2019s Laboratories (Promius), and Eli Lilly and Company. Robert E. Shapiro, MD, Ph.D., serves as consultant and\/or advisory board member or has received honoraria or research support from Eli Lilly and Company, AbbVie, Theranica, and Lundbeck. Susan Hutchinson, MD, has consulted for and\/or spoken at or received honoraria from Alder\/Lundbeck, AbbVie\/Allergan, Amgen, Biohaven, Currax, electroCore, Eli Lilly and Company, Impel, Novartis, Teva, Theranica, and Upsher-Smith. Anthony Zagar, MS, is an employee and minor stockholder of Eli Lilly and Company. Robert A. Nicholson, Ph.D., is an employee and minor stockholder of Eli Lilly and Company. Richard B. Lipton, MD, has received research support from the National Institutes of Health, the FDA, and the National Headache Foundation. He serves as a consultant or advisory board member or has received honoraria or research support from AbbVie\/Allergan, Amgen, Biohaven, Dr. Reddy\u2019s Laboratories (Promius), electroCore, Eli Lilly and Company, GlaxoSmithKline, Lundbeck, Merck, Novartis, Pfizer, Teva, Vector, and Vedanta Research. He receives royalties from Wolff\u2019s Headache, eighth edition (Oxford University Press, 2009) and Informa. He holds stock\/options in Axon, Biohaven, CoolTech, and Manistee Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by Sterling Institutional Review Board (IRB ID #6425\u2013001) and the participants provided informed consent prior to the start of the study. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}